Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,202 | 67,041 | 60,595 | 57,936 | 55,019 |
| Marketable Securities | 178,796 | 220,424 | 268,122 | 296,590 | 309,347 |
| Receivables | 40,744 | 32,219 | 28,164 | 30,005 | 27,656 |
| Inventories | 36,051 | 43,900 | 31,241 | 22,625 | 18,285 |
| TOTAL | $342,041 | $391,706 | $409,036 | $427,849 | $429,926 |
| Non-Current Assets | |||||
| PPE Net | 15,398 | 15,079 | 14,542 | 7,465 | 6,790 |
| Other Non-Current Assets | 12,917 | 11,045 | 5,531 | 4,934 | 7,791 |
| TOTAL | $28,315 | $26,124 | $20,073 | $12,399 | $14,581 |
| Total Assets | $370,356 | $417,830 | $429,109 | $440,248 | $444,507 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54,537 | 70,878 | 86,663 | 91,506 | 88,521 |
| Accounts payable and accrued liabilities | 4,314 | 12,467 | 4,089 | 4,079 | 3,331 |
| Accrued Expenses | 45,679 | 45,561 | 43,663 | 49,529 | 43,020 |
| TOTAL | $108,041 | $135,417 | $138,662 | $149,361 | $139,119 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,308 | 14,083 | 18,742 | 34,874 | 57,940 |
| Deferred Revenues | 3,511 | 6,511 | 4,247 | 4,247 | 4,247 |
| Other Non-Current Liabilities | 6,407 | 6,532 | 7,149 | 2,118 | 2,203 |
| TOTAL | $16,962 | $22,361 | $30,400 | $42,000 | $65,650 |
| Total Liabilities | $125,003 | $157,778 | $169,062 | $191,361 | $204,769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,540 | 146,311 | 145,509 | 145,033 | 144,558 |
| Common Shares | 147 | 146 | 145 | 145 | 145 |
| Retained earnings | -569,281 | -544,266 | -529,642 | -531,438 | -529,311 |
| Other shareholders' equity | 392 | 390 | 61 | -277 | -478 |
| TOTAL | $245,353 | $260,052 | $260,047 | $248,887 | $239,738 |
| Total Liabilities And Equity | $370,356 | $417,830 | $429,109 | $440,248 | $444,507 |